A clinical trial of GMRx2 in patients with mild to moderate hypertension
Latest Information Update: 24 Oct 2024
Price :
$35 *
At a glance
- Drugs Amlodipine/indapamide/telmisartan-George Medicines (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 24 Oct 2024 New trial record